AAPL326.57+11.23 (+3.56%) ▲|ABBV255.00+4.09 (+1.63%) ▲|ABT103.57+0.20 (+0.19%) ▲|ACN180.39+2.49 (+1.40%) ▲|ADBE245.07-3.76 (-1.51%) ▼|AMAT457.40+3.39 (+0.75%) ▲|AMD503.03-0.57 (-0.11%) ▼|AMGN384.30+1.83 (+0.48%) ▲|AMT175.60+2.61 (+1.51%) ▲|AMZN256.21+4.32 (+1.72%) ▲|AVGO363.48+2.65 (+0.73%) ▲|AXP324.91+4.18 (+1.30%) ▲|BA208.54+3.69 (+1.80%) ▲|BAC63.78+1.21 (+1.93%) ▲|BKNG174.28+0.37 (+0.21%) ▲|BLK1,080.99+18.45 (+1.74%) ▲|BMY64.05+0.31 (+0.48%) ▲|BNY164.33+1.72 (+1.05%) ▲|BRK-B509.04+2.03 (+0.40%) ▲|C140.92+2.39 (+1.72%) ▲|CAT817.78+12.78 (+1.59%) ▲|CL88.34+0.45 (+0.51%) ▲|CMCSA25.31+0.14 (+0.54%) ▲|COF210.58+3.49 (+1.69%) ▲|COP135.82-1.23 (-0.90%) ▼|COST905.11+2.73 (+0.30%) ▲|CRM247.90+4.80 (+1.97%) ▲|CSCO109.40+1.96 (+1.82%) ▲|CVS96.04+0.75 (+0.79%) ▲|CVX213.29+0.53 (+0.25%) ▲|DE689.56+11.61 (+1.71%) ▲|DHR202.36+1.88 (+0.94%) ▲|DIS106.49+0.64 (+0.61%) ▲|DUK119.81+0.41 (+0.34%) ▲|EMR150.20+1.82 (+1.23%) ▲|FDX314.52+2.70 (+0.86%) ▲|GD355.64+1.35 (+0.38%) ▲|GE328.12+4.00 (+1.23%) ▲|GEV950.00+26.61 (+2.88%) ▲|GILD145.64+0.83 (+0.57%) ▲|GM87.15+1.05 (+1.22%) ▲|GOOG337.20+6.81 (+2.06%) ▲|GOOGL339.35+6.75 (+2.03%) ▲|GS1,037.83+18.10 (+1.77%) ▲|HD311.00+5.30 (+1.73%) ▲|HON203.43+1.25 (+0.62%) ▲|IBM236.56+2.49 (+1.06%) ▲|INTC101.41+1.09 (+1.08%) ▲|INTU318.36+5.59 (+1.79%) ▲|ISRG372.53+12.07 (+3.35%) ▲|JNJ269.03+2.69 (+1.01%) ▲|JPM359.72+6.23 (+1.76%) ▲|KO88.40+0.57 (+0.65%) ▲|LIN464.16+2.54 (+0.55%) ▲|LLY1,127.01+3.74 (+0.33%) ▲|LMT529.21-0.77 (-0.15%) ▼|LOW199.46+2.86 (+1.46%) ▲|LRCX299.94+1.93 (+0.65%) ▲|MA568.38+2.96 (+0.52%) ▲|MCD253.82+0.79 (+0.31%) ▲|MDLZ62.69+0.22 (+0.35%) ▲|MDT92.25+0.63 (+0.69%) ▲|META659.47+15.09 (+2.34%) ▲|MMM163.29+0.43 (+0.26%) ▲|MO69.49+0.73 (+1.06%) ▲|MRK145.06+0.34 (+0.23%) ▲|MS216.60+3.89 (+1.83%) ▲|MSFT496.81+4.37 (+0.89%) ▲|MU978.18+0.77 (+0.08%) ▲|NEE82.95+0.49 (+0.59%) ▲|NFLX76.94+0.93 (+1.22%) ▲|NKE36.94+0.33 (+0.89%) ▲|NOW133.76+2.58 (+1.97%) ▲|NVDA219.49+1.13 (+0.52%) ▲|ORCL156.50+3.33 (+2.17%) ▲|PEP136.99+0.34 (+0.25%) ▲|PFE27.66+0.02 (+0.07%) ▲|PG144.83+1.83 (+1.28%) ▲|PLTR166.88+1.02 (+0.61%) ▲|PM192.68+2.95 (+1.55%) ▲|QCOM181.56+4.68 (+2.65%) ▲|RTX198.38+0.30 (+0.15%) ▲|SBUX99.78+0.56 (+0.56%) ▲|SCHW106.72-0.61 (-0.57%) ▼|SO88.21+0.46 (+0.52%) ▲|SPG205.01+0.27 (+0.13%) ▲|T25.91+0.35 (+1.35%) ▲|TMO609.66+6.51 (+1.08%) ▲|TMUS180.03+2.87 (+1.62%) ▲|TSLA364.96+1.40 (+0.38%) ▲|TXN267.37+8.55 (+3.30%) ▲|UBER72.19-0.37 (-0.51%) ▼|UNH385.23-3.05 (-0.79%) ▼|UNP287.61+1.83 (+0.64%) ▲|UPS100.00+0.03 (+0.03%) ▲|USB62.88+0.47 (+0.75%) ▲|V368.49+1.28 (+0.35%) ▲|VZ50.40+0.43 (+0.86%) ▲|WFC90.41+0.96 (+1.07%) ▲|WMT106.20+0.47 (+0.44%) ▲|XOM165.55+0.32 (+0.19%) ▲|AAPL326.57+11.23 (+3.56%) ▲|ABBV255.00+4.09 (+1.63%) ▲|ABT103.57+0.20 (+0.19%) ▲|ACN180.39+2.49 (+1.40%) ▲|ADBE245.07-3.76 (-1.51%) ▼|AMAT457.40+3.39 (+0.75%) ▲|AMD503.03-0.57 (-0.11%) ▼|AMGN384.30+1.83 (+0.48%) ▲|AMT175.60+2.61 (+1.51%) ▲|AMZN256.21+4.32 (+1.72%) ▲|AVGO363.48+2.65 (+0.73%) ▲|AXP324.91+4.18 (+1.30%) ▲|BA208.54+3.69 (+1.80%) ▲|BAC63.78+1.21 (+1.93%) ▲|BKNG174.28+0.37 (+0.21%) ▲|BLK1,080.99+18.45 (+1.74%) ▲|BMY64.05+0.31 (+0.48%) ▲|BNY164.33+1.72 (+1.05%) ▲|BRK-B509.04+2.03 (+0.40%) ▲|C140.92+2.39 (+1.72%) ▲|CAT817.78+12.78 (+1.59%) ▲|CL88.34+0.45 (+0.51%) ▲|CMCSA25.31+0.14 (+0.54%) ▲|COF210.58+3.49 (+1.69%) ▲|COP135.82-1.23 (-0.90%) ▼|COST905.11+2.73 (+0.30%) ▲|CRM247.90+4.80 (+1.97%) ▲|CSCO109.40+1.96 (+1.82%) ▲|CVS96.04+0.75 (+0.79%) ▲|CVX213.29+0.53 (+0.25%) ▲|DE689.56+11.61 (+1.71%) ▲|DHR202.36+1.88 (+0.94%) ▲|DIS106.49+0.64 (+0.61%) ▲|DUK119.81+0.41 (+0.34%) ▲|EMR150.20+1.82 (+1.23%) ▲|FDX314.52+2.70 (+0.86%) ▲|GD355.64+1.35 (+0.38%) ▲|GE328.12+4.00 (+1.23%) ▲|GEV950.00+26.61 (+2.88%) ▲|GILD145.64+0.83 (+0.57%) ▲|GM87.15+1.05 (+1.22%) ▲|GOOG337.20+6.81 (+2.06%) ▲|GOOGL339.35+6.75 (+2.03%) ▲|GS1,037.83+18.10 (+1.77%) ▲|HD311.00+5.30 (+1.73%) ▲|HON203.43+1.25 (+0.62%) ▲|IBM236.56+2.49 (+1.06%) ▲|INTC101.41+1.09 (+1.08%) ▲|INTU318.36+5.59 (+1.79%) ▲|ISRG372.53+12.07 (+3.35%) ▲|JNJ269.03+2.69 (+1.01%) ▲|JPM359.72+6.23 (+1.76%) ▲|KO88.40+0.57 (+0.65%) ▲|LIN464.16+2.54 (+0.55%) ▲|LLY1,127.01+3.74 (+0.33%) ▲|LMT529.21-0.77 (-0.15%) ▼|LOW199.46+2.86 (+1.46%) ▲|LRCX299.94+1.93 (+0.65%) ▲|MA568.38+2.96 (+0.52%) ▲|MCD253.82+0.79 (+0.31%) ▲|MDLZ62.69+0.22 (+0.35%) ▲|MDT92.25+0.63 (+0.69%) ▲|META659.47+15.09 (+2.34%) ▲|MMM163.29+0.43 (+0.26%) ▲|MO69.49+0.73 (+1.06%) ▲|MRK145.06+0.34 (+0.23%) ▲|MS216.60+3.89 (+1.83%) ▲|MSFT496.81+4.37 (+0.89%) ▲|MU978.18+0.77 (+0.08%) ▲|NEE82.95+0.49 (+0.59%) ▲|NFLX76.94+0.93 (+1.22%) ▲|NKE36.94+0.33 (+0.89%) ▲|NOW133.76+2.58 (+1.97%) ▲|NVDA219.49+1.13 (+0.52%) ▲|ORCL156.50+3.33 (+2.17%) ▲|PEP136.99+0.34 (+0.25%) ▲|PFE27.66+0.02 (+0.07%) ▲|PG144.83+1.83 (+1.28%) ▲|PLTR166.88+1.02 (+0.61%) ▲|PM192.68+2.95 (+1.55%) ▲|QCOM181.56+4.68 (+2.65%) ▲|RTX198.38+0.30 (+0.15%) ▲|SBUX99.78+0.56 (+0.56%) ▲|SCHW106.72-0.61 (-0.57%) ▼|SO88.21+0.46 (+0.52%) ▲|SPG205.01+0.27 (+0.13%) ▲|T25.91+0.35 (+1.35%) ▲|TMO609.66+6.51 (+1.08%) ▲|TMUS180.03+2.87 (+1.62%) ▲|TSLA364.96+1.40 (+0.38%) ▲|TXN267.37+8.55 (+3.30%) ▲|UBER72.19-0.37 (-0.51%) ▼|UNH385.23-3.05 (-0.79%) ▼|UNP287.61+1.83 (+0.64%) ▲|UPS100.00+0.03 (+0.03%) ▲|USB62.88+0.47 (+0.75%) ▲|V368.49+1.28 (+0.35%) ▲|VZ50.40+0.43 (+0.86%) ▲|WFC90.41+0.96 (+1.07%) ▲|WMT106.20+0.47 (+0.44%) ▲|XOM165.55+0.32 (+0.19%) ▲|
21.9 C
New York
Friday, September 11, 2026

Tag: actions

newssourceFORcompanyinformationcontent1releasesmarket

IOVA FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July...

NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline.

HIMS FRAUD ALERT: Hims & Hers Health, Inc. 34% Stock Drop Triggers Securities Fraud Class Action – Investors Notified to Contact BFA Law by...

Hims & Hers Health, Inc. investors that lost money are notified to contact BFA Law before the August 25, 2025 securities fraud class action deadline.

RDDT FRAUD ALERT: Reddit, Inc. 9% Stock Drop Triggers Securities Fraud Class Action – Investors Notified to Contact BFA Law by August 18 (NYSE:RDDT)

Reddit, Inc. investors that lost money are notified to contact BFA Law before the August 18, 2025 securities fraud class action deadline.

Graphene Manufacturing Group Ltd. Announces Agreement for At-The-Market Offering

/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/ BRISBANE, Australia, July 11, 2025 /CNW/ - Graphene Manufacturing Group Ltd. (TSXV: GMG)...

LAZYDAYS ANNOUNCES CLOSING OF 1-FOR-30 REVERSE STOCK SPLIT

TAMPA, Fla., July 11, 2025 /PRNewswire/ -- Lazydays Holdings, Inc. ("Lazydays" or the "Company") (NasdaqCM: GORV) today announced that the Company filed a Certificate of...

Edward and Ludmila Smolyansky Provide Update on the Definitive Consent Solicitation Process Currently Underway and Respond to Lifeway Foods, Inc. (NASDAQ: LWAY)

CHICAGO, July 11, 2025 /PRNewswire/ -- Edward and Ludmila Smolyansky, long-term shareholders of Lifeway Foods, Inc. (NASDAQ: LWAY) who together exercise voting control with...

Rosen Law Firm Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation – EGBN

NEW YORK, July 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on...

RIBER: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL AU 30 JUIN 2025

Bezons, le 11 juillet 2025, 19h00

Valneva Announces Lifting of European Medicines Agency’s Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly

Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 years and above after concluding a thorough review of Valneva’s single-dose chikungunya vaccine IXCHIQ® by EMA’s safety committee (PRAC).

Valneva annonce la levée de la restriction temporaire de l’Agence européenne des médicaments sur l’utilisation du vaccin contre le chikungunya IXCHIQ® chez les personnes...

Saint Herblain (France), le 11 juillet 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’agence européenne des médicaments (EMA) allait lever sa restriction temporaire sur la vaccination des personnes âgées de 65 et plus avec le vaccin à dose unique contre le chikungunya IXCHIQ® de Valneva suite à l’achèvement d’une revue complète du vaccin par le comité pour l’évaluation des risques en matière de pharmacovigilance de l’EMA (PRAC).

Rakovina Therapeutics Congratulates Partner – Variational AI for Winning LifeSciencesBC’s 2025 Emerging Biotech Company of the Year Award

Award Recognition underscores the importance of AI-driven drug discovery 
Award Recognition underscores the importance of AI-driven drug discovery

Jaylen Brown, Abdulla Al Zain & Ahsan Ashraf Join Board to Drive Innovation & Global Expansion; Riz Shah Named Chairman

New additions bolster Hapbee as it scales product reach, tech pipeline, and international presence. 
New additions bolster Hapbee as it scales product reach, tech pipeline, and international presence.

Michelin | Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital

Clermont-Ferrand, July 11th, 2025

Michelin | Déclaration du nombre total des droits de vote et du nombre d’actions composant le capital social

                                     Clermont-Ferrand, le 11 juillet 2025

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsActions

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers